Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v2-FR
Language English French
Date Updated 2017-10-10 2017-03-20
Drug Identification Number 02402297 02402297
Brand name JAMP-GABAPENTIN TABLETS JAMP-GABAPENTIN TABLETS
Common or Proper name Gabarentin Gabarentin
Company Name JAMP PHARMA CORPORATION JAMP PHARMA CORPORATION
Ingredients GABAPENTIN GABAPENTIN
Strength(s) 800MG 800MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-09-15 2016-09-15
Estimated end date 2017-09-30 2017-05-19
Actual end date 2017-10-09
Shortage status Resolved Actual shortage
Company comments
Health Canada comments